DXC Technology Signs Agreement with Temenos, Enabling its Large Bank Customers to Reimagine Core Banking Transformation
DXC Technology (NYSE: DXC)today announced that it has signed a strategic agreement with Temenos (SIX: TEMN), the banking software company to accelerate the digital transformation strategy for DXC’s large bank customers. The expanded partnership brings together the extensive cloud hosting, implementation and integration strengths of DXC with the power of Temenos industry leading banking software. The two companies will jointly offer large bank customers the optimal modernization approach to address competitive, regulatory, cost and innovation drivers.
Many large banks are having to contend with complex legacy technology stacks that can include multiple core capabilities, disparate systems and product silos. These banks are embarking on transformation projects to compete with fintechs and neobanks, whose agility allows them to rapidly launch differentiated products and attract new customers. DXC and Temenos are paving the transformation journey by empowering the banks to compete with challengers by quickly adapting their business models and offering differentiated services to their customers.
With the combined strengths of DXC and Temenos, customers can adopt a modern core banking solution, confident in their migration success and benefits of adopting a fully hosted and resilient solution.
Dmitry Loschinin, Executive Vice President, DXC Luxoft Analytics & Engineering: “We are excited to strengthen our collaboration with Temenos, the market-leading, cloud-native, banking-technology provider. Core IT systems play a central role in helping banks innovate and deliver next-generation banking services to their customers. And like any major IT transformation, this kind of enterprise-level change needs to be undertaken with the right partners. Together with Temenos, DXC’s world-class professional services and deep banking expertise will empower banking customers to begin their IT modernization journey, focusing on their core business strengths while we address the implementation.”
Max Chuard, Chief Executive Officer, Temenos said: “We are delighted to announce this strategic agreement with DXC, a proven partner for delivering strategic transformation of complex, mission-critical IT systems for financial services firms. This joint go-to-market strategy with DXC is a new channel to market for Temenos, which will accelerate our penetration in the large banks segment, notably with the U.S. market, representing approximately 60% of the total third-party market spend. Together, we seek to help larger banks with complex, legacy IT architectures break down silos, reduce IT complexity and costs, and gain greater speed to market. We can help DXC’s customers accelerate their business transformation and provide outstanding customer experiences.”
– Ends –
About DXC Technology
DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy the Enterprise Technology Stack to deliver new levels of performance, competitiveness and customer experiences. Learn more about the DXC story and our focus on people, customers and operational execution at www.dxc.technology.
Temenos AG (SIX: TEMN) is the world’s leader in banking software. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 1.2 billion banking customers. Temenos offers cloud-native, cloud-agnostic and AI-driven front office, core banking, payments and fund administration software enabling banks to deliver frictionless, omnichannel customer experiences and gain operational excellence.
Temenos software is proven to enable its top-performing clients to achieve cost-income ratios of 26.8% half the industry average and returns on equity of 29%, three times the industry average. These clients also invest 51% of their IT budget on growth and innovation versus maintenance, which is double the industry average, proving the banks’ IT investment is adding tangible value to their business.
For more information, please visit www.temenos.com.
Investor and Media Contacts
Head of Investor Relations, Temenos
Tel: +41 22 708 1515
Teneo for Temenos
Tel: +44 203 757 9257
DXC Corporate Media Relations,
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Universal Peace Federation: Millions of participants from 150 countries joined the live online broadcast of the 5 th Rally of Hope3.3.2021 19:43:00 CET | Press release
Millions of participants from 150 countries joined the live online broadcast of the 5th Rally of Hope sponsored by the Universal Peace Federation (UPF) on Saturday, February 27, 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005853/en/ Dr. Hak Ja Han Moon, Co-Founder of Universal Peace Federation delivering her message of peace to the online participants of the 5th Rally of Hope. (Photo: Business Wire) The virtual event featured world-class entertainment and globally renowned leaders including Cape Verde President Jorge Carlos Fonseca; Guyana Prime Minister Mark Phillips; U.S. Vice President Mike Pence (2017-2021); United Nations World Food Programme Executive Director David Beasley; City of Refuge Church Bishop Noel Jones; South Africa President F.W. de Klerk (1989-1994); India Vice President Mohammad Hamid Ansari (2007-2017); Oxford Vaccine co-developer Dr. Sarah Gilbert; and East Timor President Xanana Gusmão
AGCO Announces Farmer-First Strategy3.3.2021 17:50:00 CET | Press release
AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, today announced its farmer-first strategy designed to maximize value creation for its key stakeholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005773/en/ AGCO Announces Farmer-First Strategy (Photo: Business Wire) During its 2021 Virtual Analyst Briefing, Eric Hansotia, AGCO’s Chairman, President and CEO introduced AGCO’s new Purpose and Vision statements that, when combined, offer powerful insight into the role AGCO intends to play for farmers and within the agriculture industry. AGCO’s Purpose is to deliver “Farmer-focused solutions to sustainably feed our world” and its Vision is to be the “Trusted partner for industry-leading, smart farming solutions.” AGCO will realize its Purpose and Vision by continuing to leverage its award-winning, differentiated brand portfolio to offer
Norwegian Emergency Health Services Gain Nationwide Collaboration Through Motorola Solutions’ Unified Control Room Solution3.3.2021 17:27:00 CET | Press release
Health services are a critical discipline, where every second counts and the control room is at the heart of their mission-critical operations. Teams require collaboration and flexibility to effectively manage emergency health situations as they arise. This has become especially apparent with the ongoing COVID-19 pandemic, where pressures on health services including medical communication centres, continue to rise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210302005158/en/ (Photo: Business Wire) Motorola Solutions announced today it has been awarded a contract by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to provide the Norwegian Health Emergency Service with a new CommandCentral Control Room Solution (CRS). “The new control room solution allows for significant improvements to efficiency and scalability, providing the much-needed flexibility between mission-critical teams”, said Lars Erik Tandsæther, CEO
H.I.G. Capital Expands European WhiteHorse Team with the Addition of Michael Lucas3.3.2021 17:08:00 CET | Press release
H.I.G. Capital, LLC ("H.I.G."), a leading global alternative investment firm with over €35 billion of equity capital under management, is pleased to announce the expansion of its European WhiteHorse team with the addition of Michael Lucas as a Managing Director. Michael will be based in H.I.G.’s London office. Michael has 27 years of experience in leveraged finance and direct lending. Prior to joining H.I.G., he was a Founding Partner and Head of the UK at Bridgepoint Credit. Prior to that, he spent over 20 years at ING where he was most recently acting as Global Head of Financial Sponsors. Commenting on the hire, Pascal Meysson, Head of H.I.G. WhiteHorse Europe, said, “We are thrilled to have Michael join the firm. He is one of the most respected and well-known professionals within the direct lending community in Europe, and I am confident he will have an immediate impact on our growing European direct lending platform.” About H.I.G. Capital H.I.G. is a leading global alternative asse
NZMP™ Customers Set to Benefit From New Carbonzero Certified Ingredients3.3.2021 17:00:00 CET | Press release
NZMP™, Fonterra’s dairy ingredient and solutions brand, has launched a new carbonzero certified Organic Butter. Debuting its launch in North America, the new Organic Butter will help NZMP’s customers to achieve their own sustainability goals and meet consumer demand for more sustainable products. With 72 per cent of global consumers expressing an interest in brands that actively communicate achievements around sustainability1, the introduction of carbonzero ingredients is just one way in which NZMP™ customers can leverage Fonterra’s sustainability solutions. NZMP’s™ first certified carbonzero ingredient has been audited and verified by Toitū Envirocare, an independent certifier. Lara Phillips, Senior Manager of Fonterra Sustainability Solutions, says: “Climate change is one of the most pressing challenges of our time and we’re committed to finding solutions to reduce our footprint further as part of our ongoing journey in sustainability. “To obtain carbonzero certification for an ingre
CORRECTING and REPLACING Monument Re Acquires Variable Annuity Portfolio From Athora Ireland Plc.3.3.2021 16:07:00 CET | Press release
Headline of release should read: Monument Re Acquires Variable Annuity Portfolio From Athora Ireland Plc. (instead of Monument Re Acquires Variable Annuity Portfolio From Athora Life Plc.). The updated release reads: MONUMENT RE ACQUIRES VARIABLE ANNUITY PORTFOLIO FROM ATHORA IRELAND PLC. Monument Re announced today that, subject to necessary Irish High Court and regulatory approvals, it has agreed to acquire the closed-block portfolio of variable annuities from Athora Ireland plc, a wholly-owned subsidiary of Athora Holding Ltd. Financial terms of the transaction were not disclosed. “We are pleased to have reached agreement with Athora to acquire this block of business which further reinforces our position as the market leading consolidator in Ireland,” said Manfred Maske, CEO of Monument Re. About Athora Holding Ltd. Athora is a specialised insurance and reinsurance group fully focused on the European market. Athora dedicates its focus, capital, time and technical insights to offerin
Altasciences Conducts Phase I Study in Healthy Normal Subjects for RLS-0071 for Treatment of Acute Lung Injury Due to COVID-19 Pneumonia3.3.2021 15:41:00 CET | Press release
Altasciences is pleased to support ReAlta Life Sciences by conducting a Phase I trial to evaluate RLS-0071 for treatment of Acute Lung Injury (ALI) as a result of viral infections, such as COVID-19, respiratory syncytial virus (RSV), and influenza. As part of the ReAlta ALI program underway, the Phase I trial is a single-ascending dose, randomized, double-blind, placebo-controlled, adaptive-design study to evaluate the safety, tolerability, PK, and PD of RLS-0071 in healthy subjects, performed at the Altasciences clinical pharmacology unit in Montreal, Canada. Ingrid Holmes, Vice President, Global Clinical Operations at Altasciences, says, “Our teams are proud to have the opportunity to be involved in the clinical conduct and bioanalytical analysis for this important first-in-human trial. Being able to prioritize COVID-19 therapies by contributing critical data to the development of potentially life-altering medications, such as RLS-0071, is tremendously rewarding to our teams.” Click
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom